Jamie Christensen - 03 Dec 2021 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP, Chief Scientific Officer
Signature
/s/ Vickie Reed, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Dec 2021
Net transactions value
-$157,078
Form type
4
Filing time
07 Dec 2021, 16:52:10 UTC
Previous filing
25 May 2021
Next filing
17 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +6,856 +13% $0.000000 60,706 03 Dec 2021 Direct F1
transaction MRTX Common Stock Sale $155,890 -1,192 -2% $130.78 59,514 06 Dec 2021 Direct F2
transaction MRTX Common Stock Sale $1,188 -9 -0.02% $132.00 59,505 06 Dec 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Performance Stock Units ("PSUs"). 50% of the PSUs have vested on December 3, 2021 (the "Achievement Date"), and the remaining 50% shall vest on the one-year anniversary of the Achievement Date, subject to Dr. Christensen's continuous service.
F2 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the PSUs referenced in Footnote 1.